Search Tag: #ISICEM21

ICU Management

Isicem21-advances-in-resistant-gram-negative-pneumonia

2021 03 Sep

In an interesting discussion at the 40th ISICEM International Symposium on Intensive Care & Emergency Medicine,  Richard Wunderink, Professor of Medicine, Pulmonary and Critical Care Division of Northwestern University’s Feinberg School of Medicine and Medical Director, Medical ICU, Northwestern Memorial Hospital, Chicago, discussed rising levels of...Read more

ICU Management

Isicem21-cov-barrier-study-baricitinib-for-covid-19

2021 03 Sep

A study was conducted to evaluate the efficacy and safety of baricitinib, an oral selective Janus kinase 1/2 inhibitor, in combination with standard of care for the treatment of hospitalised patients with COVID-19. A total of 1525 participants were enrolled from 101 centres across 12 countries in Asia, Europe, North America and South America. COVID-19...Read more

ICU Management

Isicem21-awake-prone-positioning-for-covid-19-acute-hypoxaemic-respiratory-failure

2021 02 Sep

Results from the awake prone positioning for COVID-19 acute hypoxaemic respiratory failure meta-trial were presented by Oriol Roca, Critical Care Specialist, Vall d'Hebron University Hospital, Barcelona, Spain, at the 40th ISICEM International Symposium on Intensive Care & Emergency Medicine in Brussels.   Awake prone positioning has been shown to...Read more

ICU Management

Isicem21-findings-from-the-rest-trial

2021 01 Sep

Acute hypoxaemic respiratory failure is a leading cause of admission to ICUs and is associated with significant mortality and morbidity. Many patients affected by acute hypoxaemic respiratory failure meet the diagnostic criteria for acute respiratory distress syndrome. An important intervention that has been shown to reduce mortality in patients with...Read more

ICU Management

Isicem21-ecmo-for-covid-19

2021 01 Sep

At the 40th ISICEM International Symposium on Intensive Care & Emergency Medicine this week, Professor Alain Combes of Sorbonne University, Paris, talked about treating COVID-19 patients with the most severe forms of cardiac and respiratory failure.   Prof Combes talked about his experience during the pandemic and presented his research that compared...Read more